Location History:
- La Jolla, CA (US) (2018 - 2022)
- Satellite Beach, FL (US) (2022 - 2024)
- Orlando, FL (US) (2024)
Company Filing History:
10 out of 90 
2 out of 1,311 
1 out of 99 
Years Active: 2018-2025
Title: The Innovative Mind of Paul M Hershberger: A Pioneer in Apelin Receptor Research
Introduction: Paul M Hershberger, based in La Jolla, California, is a notable inventor recognized for his substantial contributions to medical research. With a remarkable portfolio of ten patents, he has been at the forefront of developing therapies targeting a range of cardiovascular, renal, and metabolic diseases. His innovative work has the potential to impact many lives positively.
Latest Patents: Hershberger’s latest patents focus on apelin receptor agonists, which are instrumental in the treatment of various diseases. One significant patent highlights the use of agonists of the apelin receptor for treating diseases related to cardiovascular, renal, and metabolic conditions. Additionally, another patent outlines substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists, continuing to support treatment methods for the same range of health issues. These discoveries showcase his commitment to advancing medical science through innovation.
Career Highlights: Throughout his career, Paul M Hershberger has been associated with prominent research institutions. His tenure at the Sanford Burnham Prebys Medical Discovery Institute as well as the Sanford Burnham Medical Research Institute underscores his dedication to pushing the boundaries of medical research. His extensive background has equipped him with the expertise to pursue groundbreaking inventions.
Collaborations: Hershberger has collaborated with esteemed colleagues in his field, including Anthony B Pinkerton and Patrick R Maloney. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation, driving forward the research that leads to significant advancements in medical treatments.
Conclusion: Paul M Hershberger exemplifies the qualities of a successful inventor and researcher. His advancements in the field of apelin receptor agonists are poised to bring forth new hope for patients suffering from complex diseases. His work not only enriches the medical community but also leaves a lasting legacy in the world of innovations and inventions.